Neuberger Berman Group
AMPH icon

Neuberger Berman Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Neuberger Berman Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,374,125
Closed -$51M – 1977
2024
Q4 		$51M Sell
1,374,125
-240,963
-15% -$11M 0.04% 438
2024
Q3 		$78.4M Sell
1,615,088
-7,521
-0.5% -$330K 0.06% 343
2024
Q2 		$64.9M Sell
1,622,609
-37,208
-2% -$1.54M 0.05% 363
2024
Q1 		$72.9M Sell
1,659,817
-33,185
-2% -$1.71M 0.06% 345
2023
Q4 		$105M Buy
1,693,002
+205,023
+14% +$10.8M 0.09% 274
2023
Q3 		$68.4M Sell
1,487,979
-2,305
-0.2% -$126K 0.06% 335
2023
Q2 		$85.6M Buy
1,490,284
+1,059,032
+246% +$46.9M 0.08% 305
2023
Q1 		$16.2M Buy
+431,252
New +$14.1M 0.02% 656

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return